Powder: -20°C for 3 years | In solvent: -80°C for 1 year
5-BrdU (Broxuridine) 是一种核苷类似物,用于检测增殖细胞并与胸苷竞争掺入 DNA。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
50 mg | ¥ 271 | 现货 | ||
100 mg | ¥ 375 | 现货 | ||
500 mg | ¥ 671 | 现货 | ||
1 g | ¥ 1,178 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 418 | 现货 |
产品描述 | 5-BrdU (Broxuridine) , a nucleoside analog, are used in the detection of proliferating cells and competes with thymidine for incorporation into DNA. |
体外活性 | In RG2 rat glioma cells, Bromodeoxyuridine induces a progressive, dose-responsive suppression of cancer cell line and cancer stem cell population expansion. In H9 cells and BJ fibroblasts, Bromodeoxyuridine alters the cell cycle profile. [1] BrdU is stably integrated into the DNA, and thus can be used in assessment of cell proliferation and other cell procession. [2] |
体内活性 | In rat glioma RG2 tumor model, Bromodeoxyuridine (300 mg/kg, i.p. or 0.8 mg/ml, p.o.) significantly slows tumor progression. [1] |
激酶实验 | Assays are run in the presence of 100 μM ATP using 10 μM of substrate. 30 μL PROTEIN-MIX in 25% DMSO and incubated for 15 min at room temperature. 10 μL PEPTIDE-MIX is added, the mixture is incubated for 60 min at RT and stopped by adding 180 μL 6.4% TCA (final concentration: 5%). Incorporated phosphate is measured in a scintillation counter and IC50 values are calculated using a sigmoidal curve analysis program with variable hill slope[1]. |
细胞实验 | Cultures are initially plated at 2000 cells/cm2 and are quantified with a Z2 Coulter Counter. RG2 rat glioma cells are treated once with 0, 1, 10, or 50 μM BrdU for 24 hours, and cumulative growth curves were obtained over 18 days. Control and treated cells are quantified and replated at equal densities on days 5, 12, and 18 after treatment.(Only for Reference) |
别名 | 溴脲苷, BUdR, 5-溴脱氧尿嘧啶核苷, Broxuridine, 5-bromo-2'-deoxyuridine, Bromodeoxyuridine, BRDU |
分子量 | 307.1 |
分子式 | C9H11BrN2O5 |
CAS No. | 59-14-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: 2 mg/mL(6.5 mM)
H2O: 15.4 mg/mL(50 mM)
DMSO: 61 mg/mL (198.63 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
Ethanol / H2O / DMSO | 1 mM | 3.2563 mL | 16.2813 mL | 32.5627 mL | 81.4067 mL |
5 mM | 0.6513 mL | 3.2563 mL | 6.5125 mL | 16.2813 mL | |
H2O / DMSO | 10 mM | 0.3256 mL | 1.6281 mL | 3.2563 mL | 8.1407 mL |
20 mM | 0.1628 mL | 0.8141 mL | 1.6281 mL | 4.0703 mL | |
50 mM | 0.0651 mL | 0.3256 mL | 0.6513 mL | 1.6281 mL | |
DMSO | 100 mM | 0.0326 mL | 0.1628 mL | 0.3256 mL | 0.8141 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
5-BrdU 59-14-3 Cell Cycle/Checkpoint DNA Damage/DNA Repair Others Nucleoside Antimetabolite/Analog 溴脲苷 5BrdU inhibit BUdR 5-溴脱氧尿嘧啶核苷 Broxuridine 5-bromo-2'-deoxyuridine Inhibitor Bromodeoxyuridine 5 BrdU BRDU inhibitor